Lilly’s cardiovascular outcomes trial is the first to use an active comparator, finding noninferiority but not superiority of ...
Dual vs mono antiviral therapy demonstrated superior mortality reduction among high-risk, hospitalized patients with severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback